Moreover, combinatorial administration of two different redirected CAR T cells such as anti-PSCA- and anti-MUC1-specific CAR T cells (in 1: 1 ratio) in the non-small cell lung cancer (NSCLC) PDX model was more efficacious than each of them, according to Wei et al. [149]. Here, MUC1 is linked to non-small cell lung carcinoma.